These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10411169)

  • 1. Is mycophenolic acid effective for the treatment of pemphigus?
    Bystryn JC
    Arch Dermatol; 1999 Jul; 135(7):854-5. PubMed ID: 10411169
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pemphigus vulgaris with mycophenolate mofetil.
    Enk AH; Knop J
    Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH; Knop J
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based pemphigus treatment?
    Stirling L; Kirsner RS
    J Invest Dermatol; 2010 Aug; 130(8):1963. PubMed ID: 20631748
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of mycophenolate mofetil in the management of pemphigus.
    Nousari HC; Anhalt GJ
    Arch Dermatol; 1999 Jul; 135(7):853-4. PubMed ID: 10411168
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil.
    Howell SM; Bessinger GT; Altman CE; Belnap CM
    J Am Acad Dermatol; 2005 Sep; 53(3):541-3. PubMed ID: 16112379
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
    Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
    Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
    Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
    Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial and the treatment of pemphigus vulgaris.
    Margolis DJ
    J Invest Dermatol; 2010 Aug; 130(8):1964-6. PubMed ID: 20631749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus foliaceus in an adolescent.
    Adah A; Hill K; Wyatt J; Didion L
    J Pediatr; 2014 Nov; 165(5):1062.e1. PubMed ID: 25151193
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY; Tsai K; Aoki V; Santi CG; Maruta CW; Rivitti E
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
    Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.